ACP gives osteoporosis guidelines
NEWS IN BRIEF — Posted Oct. 6, 2008
The American College of Physicians published guidelines for the pharmacologic treatment of patients with osteoporosis in the Sept. 16 Annals of Internal Medicine.
The ACP recommends that physicians offer pharmacologic treatment to men and women who have known osteoporosis and to those who have had fragility fractures. Treatment should be considered for men and women at risk of developing osteoporosis, the ACP said.
Among the drugs evaluated were: bisphosphonates; calcitonin; estrogen; teriparatide; selective estrogen receptor modulators, or SERMs; testosterone; calcium and vitamin D.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2008/10/06/hlbf1006.htm.